Paul A Ellison Selected Research

cupric sulfide (CuS)

2/2018

Activatable Hybrid Nanotheranostics for Tetramodal Imaging and Synergistic Photothermal/Photodynamic Therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Paul A Ellison Research Topics

Disease

7	Neoplasms (Cancer) 01/2019 - 10/2015
2	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 12/2021
1	Acute Kidney Injury (Acute Renal Failure) 01/2023
1	Neuroinflammatory Diseases 12/2021
1	Down Syndrome (Down's Syndrome) 01/2021
1	Alzheimer Disease (Alzheimer's Disease) 01/2021
1	Lung Neoplasms (Lung Cancer) 01/2018

Drug/Important Bio-Agent (IBA)

3	RadiopharmaceuticalsIBA 01/2023 - 12/2018
2	PorphyrinsIBA 03/2018 - 02/2018
1	Povidone (Crospovidone)IBA 01/2023
1	Cisplatin (Platino)FDA LinkGeneric 01/2023
1	CurcuminIBA 01/2023
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2023
1	Radioisotopes (Radionuclides)IBA 12/2021
1	Staphylococcal Protein A (Protein A)IBA 12/2021
1	Biomarkers (Surrogate Marker)IBA 12/2021
1	Amyloid beta-PeptidesIBA 01/2021
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 03/2018
1	Chelating AgentsIBA 03/2018
1	Deferoxamine (Desferal)FDA LinkGeneric 03/2018
1	Liposomes (Liposome)IBA 03/2018
1	Sulfides (Thioethers)IBA 02/2018
1	cupric sulfide (CuS)IBA 02/2018
1	Silicon Dioxide (Silica)FDA LinkGeneric 02/2018
1	CopperIBA 02/2018
1	Monoclonal AntibodiesIBA 01/2018
1	NivolumabIBA 01/2018
1	Acetates (Acetic Acid Esters)FDA Link 10/2015
1	ChloridesIBA 10/2015

Therapy/Procedure

4	Precision Medicine 01/2019 - 02/2018
3	Therapeutics 12/2021 - 01/2018
2	Photochemotherapy (Photodynamic Therapy) 03/2018 - 02/2018
1	Photothermal Therapy 02/2018
1	Immunotherapy 01/2018
1	Drug Therapy (Chemotherapy) 01/2018
1	Molecular Targeted Therapy 01/2018